Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodJazz Pharmaceuticals reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 4 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Budget/Appropriations8/8
- Health Issues8/8
- Medical/Disease Research/Clinical Labs8/8
- Medicare/Medicaid8/8
- Pharmacy8/8
Trade (domestic/foreign) 2 of 8 · Show all 6
- Trade (domestic/foreign)2/8
Bills named in the filings 13 bills, this period
- S. 1862 / H.R. 946 ORPHAN Cures Act11 filings
- S. 2256 / H.R. 4121 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 Broad bill3 filings
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill2 filings
- H.R. 10545, 118th American Relief Act, 2025 Broad bill2 filings
- H.R. 1968 Full-Year Continuing Appropriations and Extensions Act, 2025 Broad bill2 filings
8 more, 7 named in only one filing · Show all 13
- H.R. 8467, 118th Farm, Food, and National Security Act of 2024 Broad bill2 filings
- H.R. 8412, 118th Clinical Trial Modernization Act1 filing
- S. 2860, 118th SAFER Banking Act1 filing
- S. 3019 No Big Blockbuster Bailouts Act1 filing
- S. 3131 / H.R. 5539, 118th ORPHAN Cures Act1 filing
- S. 891 Bipartisan Health Care Act1 filing
- H.Con.Res. 14 Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Broad bill1 filing
- H.R. 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 Broad bill1 filing
From the filings
“Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 946/S. 1862, ORPHAN Cures Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA)”
“Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing, including orphan drugs”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- FDA
- CMS
- EOP
- OMB
- USTR
- Treasury
- White House Office
The House and Senate appear in every quarter; agencies in 7 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Jazz Pharmaceuticals, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 27 sitting members of Congress and 1 other candidate in 2025–26.
See every candidate and member Jazz Pharmaceuticals gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in